![](https://i.imgur.com/CLvY2jA.png")
15-09-2021, 09:49 AM
US demand for COVID-19 antibody treatments rising fast
The cost of the monoclonal antibody treatments for COVID-19 remains a thorny issue. REGEN-COV has a list price of about $1,250 per dose, while sotrovimab is more than $2,000 per dose, although Regeneron’s product is free to patients as the bill is paid by the federal government.
GSK has a co-pay programme for commercial patients and, due to previous government relief bills, patients with Medicare and Medicaid, and the uninsured, don’t have to pay to get the treatment.
https://www.pmlive.com/pharma_news/us_de...st_1376021
The cost of the monoclonal antibody treatments for COVID-19 remains a thorny issue. REGEN-COV has a list price of about $1,250 per dose, while sotrovimab is more than $2,000 per dose, although Regeneron’s product is free to patients as the bill is paid by the federal government.
GSK has a co-pay programme for commercial patients and, due to previous government relief bills, patients with Medicare and Medicaid, and the uninsured, don’t have to pay to get the treatment.
https://www.pmlive.com/pharma_news/us_de...st_1376021
